Years ago, I watched cystic fibrosis (CF) patients receive nebulized glutathione that didn’t seem to help.
Decades later, our team developed and patented the first fully functional, reduced, and stable form — VARS Glutathione.
Why does this matter? Because CF isn’t just a mucus disease — it’s an inflammatory cytokine storm driven by IL-8, IL-4, IL-5, and IL-13.
Our research shows that restoring glutathione levels can calm these cytokines, reduce inflammation, and possibly change how we approach CF and other chronic inflammatory conditions.
Science is catching up — and hope is being restored.
